echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The 2022 collection target has been released!

    The 2022 collection target has been released!

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 10, Premier Li Keqiang presided over an executive meeting of the State Council to deploy and accelerate major projects identified in the "14th Five-Year Plan" Outline and special plans to expand effective investment; it was decided to normalize and institutionalize the development of pharmaceuticals and high-value medical consumables.
    Centralized procurement with volume to further reduce the medical burden on patients
    .
    The meeting also pointed out that in recent years, the reform of centralized procurement of medicines and high-value medical consumables has been continuously advanced, and the market-oriented mechanism has effectively suppressed the inflated prices of medicines.
    This enables pharmaceutical companies to devote more energy to product development and quality improvement
    .
    In the next step, it is necessary to promote the normalization and institutionalization of centralized and volume-based procurement and accelerate the expansion of coverage, and continue to reduce the price of medicines to benefit patients
    .
    The first is to focus on chronic diseases and common diseases, continue to promote the centralized procurement of drugs at the national level, and carry out provincial or inter-provincial alliance procurement of drugs outside the national centralized procurement
    .
    By the end of this year, there will be more than 350 medicines in each province at the national and provincial levels
    .
    The second is to gradually expand the coverage of centralized procurement of high-value medical consumables, and conduct centralized procurement at the national and provincial levels for orthopedic consumables, drug balloons, and dental implants that are of concern to the public
    .
    The third is to ensure the long-term stable supply of the selected drugs and consumables, strengthen supervision, and ensure that the price of the selected products does not deteriorate
    .
    Medical institutions should give reasonable priority to the use of the selected products
    .
    The fourth is to implement the policy of retaining the balance of medical insurance funds for centralized procurement, promote the reform of the salary system, reasonably increase the income of medical staff, and better mobilize their enthusiasm
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.